RXST
RXST
NASDAQ · Health Care

Rxsight Inc

$8.39
+0.57 (+7.29%)
As of Feb 8, 1:57 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 46.45M 45.49M 50.58M
Net Income 6.54M 7.66M 6.55M
EPS
Profit Margin 14.1% 16.8% 12.9%
Rev Growth +15.7% +1.5% +13.9%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 23.54M 28.42M 28.12M
Total Equity 239.27M 288.95M 248.82M
D/E Ratio 0.10 0.10 0.11
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 12.55M 11.61M 13.24M
Free Cash Flow 4.75M 5.18M 4.95M